Morepen Labs Board Approves Financial Results, Dividend Record Date

Morepen Laboratories Ltd's Board of Directors met on August 4, 2026, to approve the un-audited standalone and consolidated financial results for the quarter ended June 30, 2026. The board also set Saturday, September 19, 2026, as the record date for determining eligibility for the final dividend for the financial year ended March 31, 2026, subject to member approval at the upcoming 41st AGM. Additionally, the board approved the extension of the timeline for hiving off the Medical Devices Business into its subsidiary, Morepen Medipath Limited, and the re-appointment of Mr. Sushil Suri as Chairman & Managing Director for a further three-year term.